JYNT (The Joint) Current Deferred Revenue: $2.73 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

JYNT The Joint Corp JYNT
63 GF Score
Price $8.93
GF Value $11.19
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is The Joint Current Deferred Revenue?

The Joint JYNT -0.22% 63 Current Deferred Revenue is $2.73 Mil as of Mar. 2026. GuruFocus rates JYNT with a GF Score™ of 63/100 and a GF Value™ of $11.19 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

The Joint's current deferred revenue for the quarter that ended in Mar. 2026 was $2.73 Mil.

The Joint Current Deferred Revenue Related Terms

The Joint Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for The Joint's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Joint Current Deferred Revenue Chart

The Joint Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.43 10.43 2.52 2.84 2.80

The Joint Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.81 2.86 2.80 2.80 2.73
JYNT
63GF Score
The Joint Corp JYNT
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of $2.73 Mil mean?
The Joint (JYNT) has a Current Deferred Revenue of $2.73 Mil as of Mar. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on The Joint and its competitors.
Is The Joint's Current Deferred Revenue too high?
The Joint's current Current Deferred Revenue is $2.73 Mil. Overall, The Joint has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Joint's Current Deferred Revenue compare to PARK and WW?
The Joint's Current Deferred Revenue of $2.73 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Healthcare Providers & Services company?
A good Current Deferred Revenue depends on the Healthcare Providers & Services industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on The Joint and its competitors. The Joint's current Current Deferred Revenue is $2.73 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Joint stock overvalued right now?
Based on GuruFocus' analysis, The Joint (JYNT) is currently considered Modestly Undervalued. The stock's GF Value™ is $11.19, compared to a current price of $8.93 — trading 20.2% below its estimated fair value. The current Current Deferred Revenue is $2.73 Mil. The Joint's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For The Joint (JYNT), the current Current Deferred Revenue is $2.73 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The Joint (JYNT) Overvalued in 2026?

Based on GuruFocus' analysis, The Joint stock appears to be undervalued. The current stock price of $8.93 is trading 20.2% below its estimated GF Value™ of $11.19. GuruFocus considers The Joint to be Modestly Undervalued.

Key valuation signals for JYNT:

  • Current Deferred Revenue: $2.73 Mil
  • GF Value™: $11.19 vs. price of $8.93 (20.2% below fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the JYNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Joint Business Description

Address 16767 North Perimeter Drive, Suite 110, Scottsdale, AZ, USA, 85260
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.
63GF Score

Get the complete analysis for JYNT

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.93
Price
$11.19
GF Value